We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rua Life Sciences Plc | LSE:RUA | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 2.25% | 11.375 | 10.75 | 12.00 | 11.375 | 11.125 | 11.125 | 82,386 | 08:24:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 2.18M | -2M | -0.0323 | -3.52 | 7.06M |
TIDMAOR
RNS Number : 6467H
AorTech International PLC
02 December 2015
AorTech International plc
(the "Company")
Conversion of loan notes update
The Company announced on 26 October 2012 that it had issued secured loan notes (the "Loan Notes"). The Loan Notes were redeemed on 1 February 2013, but the Loan Note holders retained the right to receive from the Company on a change of control payment of a sum equal to 15% of the aggregate sums to shareholders. At the Annual General Meeting held on 24 September 2015 shareholder approval was obtained for the Board to take all necessary steps to allow the Company to allot shares in exchange for the surrender of these rights. The Company has now called a general meeting for the Loan Note holders on 21 December 2015 at which they are proposing to allot an aggregate of 724,917 new ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares") (representing 15% of the existing issued share capital of the Company) in exchange for the surrender of all remaining rights under the Loan Notes.
The Company has received sufficient irrevocable commitments to ensure that the resolution will be passed.
Application has been made for 724,917 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on 22 December 2015. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.
Both Eddie McDaid and Bill Brown were Loan Note holders and will be issued 47,928 and 11,982 shares respectively. Their resultant holdings will be:
Ordinary shares % holding Eddie McDaid 406,842 7.32 Bill Brown 12,389 0.22
The total number of Ordinary Shares in issue following Admission will be 5,557,695. Accordingly, the figure of 5,557,695 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
This information is provided by RNS
For further information contact:
AorTech International plc
Eddie McDaid, Chief Executive Tel: +44 (0)7802 920869
AorTech International plc
Bill Brown, Chairman Tel: +44 (0)7730 718296
finnCap Limited
Jonny Franklin-Adams/ Giles Rolls Tel: +44 20 7220 0500
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUGGCPPUPAGMG
(END) Dow Jones Newswires
December 02, 2015 02:00 ET (07:00 GMT)
1 Year Rua Life Sciences Chart |
1 Month Rua Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions